Insempra
GermanyWho owns Insempra?
Insempra is a German Biotech company, currently owned by Henkel Ventures since 2024 and 4 other investors.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Key facts
- ·Co-held by BlueYard Capital, Bayern Kapital, EQT Ventures, Henkel Ventures and Possible Ventures since 2020.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
More from Possible Ventures Fund III
Other portfolio companies in the same fund.
UK
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Insempra?
Insempra is currently owned by Henkel Ventures, Possible Ventures and 3 others, through Possible Ventures Fund III, since 2024.
When did Henkel Ventures and 4 others acquire Insempra?
Henkel Ventures and 4 others acquired Insempra in 2024.
Who has owned Insempra over time?
Insempra has been through 5 private-equity ownership periods: BlueYard Capital · via BlueYard Capital Fund II · since 2020; Bayern Kapital · via Wachstumsfonds Bayern · since 2021; EQT Ventures · via EQT Ventures II · since 2021; Henkel Ventures · via Henkel Ventures Balance-Sheet Vehicle · since 2024; Possible Ventures · via Possible Ventures Fund III · since 2024.